Actual Medicinal Product (AMP) Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd)

Stability Information

(Some stability information inherited from generic)

Stability

Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.

Notes

Data shows stability for up to 4 weeks.

Provenance

This compatibility recommendation is derived from Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd).

Generic

Emtricitabine + Rilpivirine + Tenofovir disoproxil

Formulation

Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets